Induction of CD4-independent E7-specific CD8+ memory response by heat shock fusion protein

Clinical and Vaccine Immunology

Volumn 14, Issue 8, 2007, Pages 1013-1023

  Liu, Hongwei ^a   Wu, Bill H ^a   Rowse, Gerry J ^a   Emtage, Peter C R ^a  

^a Nventa Biopharmaceuticals Corporation   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; HEAT SHOCK FUSION PROTEIN HSPE7; HEAT SHOCK PROTEIN 65; HYBRID PROTEIN; PROTEIN E7; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; BACTERIAL PROTEIN; CD4 ANTIGEN; CHAPERONIN; CYTOKINE; HEAT SHOCK PROTEIN 65, MYCOBACTERIUM; HEAT-SHOCK PROTEIN 65, MYCOBACTERIUM; ONCOGENE PROTEIN E7, HUMAN PAPILLOMAVIRUS TYPE 16; ONCOPROTEIN; PAPILLOMA VIRUS VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FEMALE; HUMAN PAPILLOMAVIRUS TYPE 16; IMMUNIZATION; LYMPHOCYTE DIFFERENTIATION; MEMORY T LYMPHOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; ANIMAL; C57BL MOUSE; GENETICS; HUMAN; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; METABOLISM; TUMOR CELL LINE; VIRUS INFECTION;

ANIMALS; ANTIGENS, CD4; ANTINEOPLASTIC AGENTS; BACTERIAL PROTEINS; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE, TUMOR; CHAPERONINS; CYTOKINES; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMANS; IMMUNIZATION; IMMUNOLOGIC MEMORY; MICE; MICE, INBRED C57BL; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; RECOMBINANT FUSION PROTEINS; T-LYMPHOCYTES, CYTOTOXIC; TUMOR VIRUS INFECTIONS;

EID: 35248898104     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00029-07     Document Type: Article

References (51)

1. Ahmed, R., and D. Gray. 1996. Immunological memory and protective immunity: understanding their relation. Science 272:54-60.
2. + CTL effector cells in mice by immunization with a stress protein-influenza virus nucleoprotein fusion molecule. Vaccine 17:373-383.
3. + T-cell memory. Immunol. Rev. 211:67-80.
4. + T cells undergoing primary and secondary responses to infection in the same host. J. Immunol. 170:4933-4942.
5. + T-cell memory and prime-boost response after dendritic-cell vaccination. Nat. Med. 11:748-756.
6. + T cell memory. Science 297:2060-2063.
7. Bourgeois, C., and C. Tanchot. 2003. CD4 T cells are required for CD8 T cell memory generation. Eur. J. Immunol. 33:3225-3231.
8. Bourgeois, C., H. Veiga-Fernandes, A. M. Joret, B. Rocha, and C. Tanchot. 2002. CD8 lethargy in the absence of CD4 help. Eur. J. Immunol. 32:2199-2207.
9. Cho, B. K., D. Palliser, E. Guillen, J. Wisniewski, R. A. Young, J. Chen, and H. N. Eisen. 2000. A proposed mechanism for the induction of cytotoxic T lymphocyte production by heat shock fusion proteins. Immunity 12:263-272.
10. Chu, N. R., H. B. Wu, T. Wu, L. J. Boux, M. I. Siegel, and L. A. Mizzen. 2000. Immunotherapy of a human papillomavirus (HPV) type 16 E7-expressing tumour by administration of fusion protein comprising Mycobacterium bovis bacille Calmette-Guerin (BCG) hsp65 and HPV16 E7. Clin. Exp. Immunol. 121:216-225.
11. + T cell-mediated antigen-specific immunotherapy in a mouse model of cervical cancer. Cancer Res. 65:2018-2025.
12. Devaraj, K., M. L. Gillison, and T. C. Wu. 2003. Development of HPV vaccines for HPV-associated head and neck squamous cell carcinoma. Crit. Rev. Oral Biol. Med. 14:345-362.
13. Feltkamp, M. C., H. L. Smits, M. P. Vierboom, R. P. Minnaar, B. M. de Jongh, J. W. Drijfhout, J. ter Schegget, C. J. Melief, and W. M. Kast. 1993. Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells. Eur. J. Immunol. 23:2242-2249.
14. Frazer, I. H. 2004. Prevention of cervical cancer through papillomavirus vaccination. Nat. Rev. Immunol. 4:46-54.
15. Govan, V. A. 2005. Strategies for human papillomavirus therapeutic vaccines and other therapies based on the E6 and E7 oncogenes. Ann. N. Y. Acad. Sci. 1056:328-343.
16. + T cells to apoptosis in vivo. J. Immunol. 169:3760-3770.
17. + T cells in vivo. J. Immunol. 169:5622-5629.
18. + T cell independent. J. Exp. Med. 191:403-408.
19. + T lymphocytes. Nature 421:852-856.
20. Kaech, S. M., S. Hemby, E. Kersh, and R. Ahmed. 2002. Molecular and functional profiling of memory CD8 T cell differentiation. Cell 111:837-851.
21. Kaech, S. M., E. J. Wherry, and R. Ahmed. 2002. Effector and memory T-cell differentiation: implications for vaccine development. Nat. Rev. Immunol. 2:251-262.
22. Lazarevic, V., A. J. Myers, C. A. Scanga, and J. L. Flynn. 2003. CD40, but not CD40L, is required for the optimal priming of T cells and control of aerosol M. tuberculosis infection. Immunity 19:823-835.
23. Li, D., H. Li, P. Zhang, X. Wu, H. Wei, L. Wang, M. Wan, P. Deng, Y. Zhang, J. Wang, Y. Liu, Y. Yu, and L. Wang. 2006. Heat shock fusion protein induces both specific and nonspecific anti-tumor immunity. Eur. J. Immunol. 36:1324-1336.
24. Lin, K. Y., F. G. Guarnieri, K. F. Staveley-O'Carroll, H. I. Levitsky, J. T. August, D. M. Pardoll, and T. C. Wu. 1996. Treatment of established tumors with a novel vaccine that enhances major histocompatibility class II presentation of tumor antigen. Cancer Res. 56:21-26.
25. Mahdavi, A., and B. J. Monk. 2005. Vaccines against human papillomavirus and cervical cancer: promises and challenges. Oncologist 10:528-538.
26. Miller, G., V. G. Pillarisetty, A. B. Shah, S. Lahrs, Z. Xing, and R. P. DeMatteo. 2002. Endogenous granulocyte-macrophage colony-stimulating factor overexpression in vivo results in the long-term recruitment of a distinct dendritic cell population with enhanced immunostimulatory function. J. Immunol. 169:2875-2885.
27. Mizzen, L. 1998. Immune responses to stress proteins: applications to infectious disease and cancer. Biotherapy 10:173-189.
28. + T-cell subsets in high risk human papillomavirus-associated pre-malignant and malignant lesions of the uterine cervix. Gynecol. Oncol. 102:22-31.
29. Naito, S., A. C. von Eschenbach, R. Giavazzi, and I. J. Fidler. 1986. Growth and metastasis of tumor cells isolated from a human renal cell carcinoma implanted into different organs of nude mice. Cancer Res. 46:4109-4115.
30. Nimako, M., A. N. Fiander, G. W. Wilkinson, L. K. Borysiewicz, and S. Man. 1997. Human papillomavirus-specific cytotoxic T lymphocytes in patients with cervical intraepithelial neoplasia grade III. Cancer Res. 57:4855-4861.
31. Padilla-Paz, L. A. 2005. Human papillomavirus vaccine: history, immunology, current status, and future prospects. Clin. Obstet. Gynecol. 48:226-240.
32. + T cell differentiation in response to a recombinant heat shock fusion protein. J. Immunol. 172:2885-2893.
33. Pockley, A. G. 2003. Heat shock proteins as regulators of the immune response. Lancet 362:469-476.
34. + T-cell responses. Curr. Opin. Immunol. 16:259-263.
35. Shedlock, D. J., and H. Shen. 2003. Requirement for CD4 T cell help in generating functional CD8 T cell memory. Science 300:337-339.
36. Reference deleted.
37. Steele, J. C., C. H. Mann, S. Rookes, T. Rollason, D. Murphy, M. G. Freeth, P. H. Gallimore, and S. Roberts. 2005. T-cell responses to human papillomavirus type 16 among women with different grades of cervical neoplasia. Br. J. Cancer 93:248-259.
38. Stern, P. L. 2005. Immune control of human papillomavirus (HPV) associated anogenital disease and potential for vaccination. J. Clin. Virol. 32(Suppl. 1):S72-S81.
39. Sun, J. C., and M. J. Bevan. 2003. Defective CD8 T cell memory following acute infection without CD4 T cell help. Science 300:339-342.
40. + T cells after acute infection. Nat. Immunol. 5:927-933.
41. + T cell responses in women with high grade vulvar intraepithelial neoplasia. Int. J. Cancer 108:857-862.
42. Valdespino, V., C. Gorodezky, V. Ortiz, A. M. Kaufmann, E. Roman-Basaure, A. Vazquez, and J. Berumen. 2005. HPV16-specific cytotoxic T lymphocyte responses are detected in all HPV16-positive cervical cancer patients. Gynecol. Oncol. 96:92-102.
43. van Eden, W., A. Koets, P. van Kooten, B. Prakken, and R. van der Zee. 2003. Immunopotentiating heat shock proteins: negotiators between innate danger and control of autoimmunity. Vaccine 21:897-901.
44. + T cells to antigen stimulation in vivo. Nat. Immunol. 1:47-53.
45. + T-cell responses. Cancer Res. 64:8761-8766.
46. + T cell responses in vivo. J. Immunol. 171:6339-6343.
47. Welsh, R. M., L. K. Selin, and E. Szomolanyi-Tsuda. 2004. Immunological memory to viral infections. Annu. Rev. Immunol. 22:711-743.
48. Wherry, E. J., V. Teichgraber, T. C. Becker, D. Masopust, S. M. Kaech, R. Antia, U. H. von Andrian, and R. Ahmed. 2003. Lineage relationship and protective immunity of memory CD8 T cell subsets. Nat. Immunol. 4:225-234.
49. + memory T cells. Immunol. Rev. 211:146-153.
50. Williamson, A. L., J. A. Passmore, and E. P. Rybicki. 2005. Strategies for the prevention of cervical cancer by human papillomavirus vaccination. Best Pract. Res. Clin. Obstet. Gynaecol. 19:531-544.
51. zur Hausen, H. 1991. Human papillomaviruses in the pathogenesis of anogenital cancer. Virology 184:9-13.